Remi Favier

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications

Corrigendum to 'Platelet dense granule defect: experience in the French population' [Research and Practice in Thrombosis and Haemostasis Volume 10, Issue 2, February 2026, 103364].

Corrigendum to 'Platelet dense granule defect: experience in the French population' [Research and Practice in Thrombosis and Haemostasis Volume 10, Issue 2, February 2026, 103364].

Journal: Research and practice in thrombosis and haemostasis
Published: July 28, 2026

Platelet dense granule defect: experience in the French population.

Platelet dense granule defect: experience in the French population.

Journal: Research and practice in thrombosis and haemostasis
Published: December 21, 2025

Increased RhoA pathway activation downstream of αIIbβ3/SRC contributes to heterozygous Bernard Soulier syndrome.

Increased RhoA pathway activation downstream of αIIbβ3/SRC contributes to heterozygous Bernard Soulier syndrome.

Journal: Haematologica
Published: August 09, 2024

Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.

Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.

Journal: Blood advances
Published: February 23, 2023

Germline RUNX1 variants in paediatric patients in a French specialised centre.

Germline RUNX1 variants in paediatric patients in a French specialised centre.

Journal: EJHaem
Published: September 17, 2022

NBEAL2 deficiency in humans leads to low CTLA-4 expression in activated conventional T cells.

NBEAL2 deficiency in humans leads to low CTLA-4 expression in activated conventional T cells.

Journal: Nature communications
Published: September 08, 2022

ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis.

ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis.

Journal: Haematologica
Published: September 05, 2022

Clonal evolution in hereditary thrombocytosis with MPL T487A mutation.

Clonal evolution in hereditary thrombocytosis with MPL T487A mutation.

Journal: Pediatric blood & cancer
Published: June 28, 2022

Mutations in Neurobeachin-like 2 do not impact Weibel-Palade body biogenesis and von Willebrand factor secretion in gray platelet syndrome Endothelial Colony Forming Cells.

Mutations in Neurobeachin-like 2 do not impact Weibel-Palade body biogenesis and von Willebrand factor secretion in gray platelet syndrome Endothelial Colony Forming Cells.

Journal: Research and practice in thrombosis and haemostasis
Published: June 09, 2022

Tranexamic acid dose-response relationship for antifibrinolysis in postpartum haemorrhage during Caesarean delivery: TRACES, a double-blind, placebo-controlled, multicentre, dose-ranging biomarker study.

Tranexamic acid dose-response relationship for antifibrinolysis in postpartum haemorrhage during Caesarean delivery: TRACES, a double-blind, placebo-controlled, multicentre, dose-ranging biomarker study.

Journal: British journal of anaesthesia
Published: April 29, 2022

A promising treatment to optimize delivery management in a pregnant woman with inherited thrombocytopenia: thrombopoietin-receptor agonist administration.

A promising treatment to optimize delivery management in a pregnant woman with inherited thrombocytopenia: thrombopoietin-receptor agonist administration.

Journal: International journal of obstetric anesthesia
Published: November 08, 2021

A thrombopoietin receptor agonist to rescue an unusual platelet transfusion-induced reaction in a p.V1316M-associated von Willebrand disease type 2B patient.

A thrombopoietin receptor agonist to rescue an unusual platelet transfusion-induced reaction in a p.V1316M-associated von Willebrand disease type 2B patient.

Journal: Therapeutic advances in hematology
Published: August 19, 2021
Showing 1-12 of 75

Last Updated: 09/26/2026